This elevates the need for an efficient, reliable cold chain
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) present a promising avenue for addressing the complex cardiovascular-kidney-metabolic health 11,12
It underscores how coverage under the pharmacy benefit (state Medicaid pharmacy plan) can quickly drive line-item spend, influencing whether a benefit is sustainable
1 However, depending on the form taken, these medications can cause a slew of unwanted effects ranging from nausea and vomiting to lean muscle loss
Some of the potential medicines coming down the pipeline include: Survodutide , mazdutide , and pemvidutide , weekly injectable drugs that work on both GLP-1 and glucagon receptors to help reduce weight and lower blood sugar Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon that comes in a once-weekly injection Pramlintide and cagrilintide, injectable drugs that work by acting on receptors for amylin, a hormone produced by the pancreas that plays a role in blood sugar control and satiety (fullness) How long will I take weight loss medications
People who may not have adequate support systems at home or feel vulnerable for one reason or another can benefit greatly from an aftercare plan in their quest to stay sober
